A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer

P Murray, K Franks, GG Hanna - The British journal of radiology, 2017 - academic.oup.com
Stereotactic ablative body radiotherapy (SABR) describes a radiotherapy (RT) technique
where high doses of radiation are precisely delivered to an extracranial target within the …

UK consensus on normal tissue dose constraints for stereotactic radiotherapy

GG Hanna, L Murray, R Patel, S Jain, KL Aitken… - Clinical Oncology, 2018 - Elsevier
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open.
Many of these involve the treatment of oligometastatic disease at different locations in the …

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—a pooled analysis of the German working group “stereotactic radiotherapy”

J Rieber, J Streblow, L Uhlmann, M Flentje, M Duma… - Lung Cancer, 2016 - Elsevier
Objectives The current literature on stereotactic body radiotherapy (SBRT) for
oligometastatic disease is characterized by small patient cohorts with heterogeneous …

The role of stereotactic ablative body radiotherapy in gynaecological cancers: a systematic review

LC Mendez, E Leung, P Cheung, L Barbera - Clinical Oncology, 2017 - Elsevier
Aims To summarise and evaluate the current literature in gynaecological tumours treated
with stereotactic ablative body radiotherapy (SABR) through a systematic review using the …

Hybrid therapy for metastatic epidural spinal cord compression: technique for separation surgery and spine radiosurgery

O Barzilai, I Laufer, A Robin, R Xu… - Operative …, 2019 - journals.lww.com
BACKGROUND Despite major advances in radiation and systemic treatments, surgery
remains a critical step in the multidisciplinary treatment of metastatic spinal cord tumors …

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical …

J Conibear, B Chia, Y Ngai, AT Bates, N Counsell… - BMJ open, 2018 - bmjopen.bmj.com
Introduction Following growing evidence to support the safety, local control (LC) and
potential improvement in overall survival (OS) in patients with oligometastatic non-small cell …

The role of radiotherapy in epidermal growth factor receptor mutation-positive patients with oligoprogression: a matched-cohort analysis

OSH Chan, VHF Lee, TSK Mok, F Mo, ATY Chang… - Clinical Oncology, 2017 - Elsevier
Aims Almost all patients with epidermal growth factor receptor (EGFR) mutations will
develop resistance to first-line EGFR tyrosine kinase inhibitors (TKIs). The management of …

Clinical outcome of stereotactic ablative body radiotherapy for lung metastatic lesions in non-small cell lung cancer oligometastatic patients

F De Rose, L Cozzi, P Navarria, AM Ascolese, E Clerici… - Clinical oncology, 2016 - Elsevier
Aims The aim of this observational study was the evaluation of toxicity, local control and
overall survival in non-small cell lung cancer (NSCLC) oligometastatic patients who had …

Effect of primary tumor location and tumor size on the response to radiotherapy for liver metastases from colorectal cancer

K Uemoto, O Suzuki, K Yamada… - Oncology …, 2017 - spandidos-publications.com
Metastatic liver tumors (MLTs) from colorectal cancer (CRC) are often treated with
stereotactic body radiation therapy (SBRT). The present study aimed to examine the …

CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy

L Yao, Y Jiang, P Jiang, H Wang, N Meng, A Qu, S Tian… - Brachytherapy, 2015 - Elsevier
Purpose To evaluate the feasibility, efficacy, and safety of permanent 125 I seed interstitial
brachytherapy reirradiation in patients with retroperitoneal lymph node recurrence under CT …